Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Mielke

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Current Opinion in Oncology|October 2, 2007
Individualized pharmacotherapy with paclitaxelStephan Mielke
British Journal of Clinical Pharmacology|June 2, 2016
New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host diseaseMathias Lutz, Stephan Mielke
European Journal of Cancer (Oxford, England : 1990)|November 19, 2005
Peripheral neuropathy: a persisting challenge in paclitaxel-based regimesStephan Mielke, Alex Sparreboom, Klaus Mross
Current Opinion in Hematology|October 9, 2014
Diagnosis and treatment of cytomegalovirus 2013Hermann Einsele, Stephan Mielke, Götz Ulrich Grigoleit
In Vivo (Athens, Greece)|November 6, 2003
Fatal outcome in a patient with metastatic prostate cancer and acquired severe hypogammaglobulinemia with complete absence of mature peripheral blood B-cellsJens Lohr, Stephan Mielke, Michael Lübbert, et al.
Anticancer Research|December 13, 2005
Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimenStephan Mielke, Alex Sparreboom, Dirk Behringer, et al.
Frontiers in Immunology|July 8, 2026
Long term survival in three pancreatic cancer patients following Whipple's procedure and allogeneic hematopoietic cell transplantationOlle Ringden, Behnam Sadeghi, Johan Törlen, et al.
Clinical Transplantation|October 8, 2014
Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimusMathias Lutz, Markus Kapp, Hermann Einsele, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 30, 2019
Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazoleVerena Luber, Mathias Lutz, Marianne Abele-Horn, et al.
Bone Marrow Transplantation|February 25, 2022
Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaHannes Lindahl, Sofie Vonlanthen, Davide Valentini, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Current Opinion in Oncology|October 2, 2007
Individualized pharmacotherapy with paclitaxelStephan Mielke
British Journal of Clinical Pharmacology|June 2, 2016
New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host diseaseMathias Lutz, Stephan Mielke
European Journal of Cancer (Oxford, England : 1990)|November 19, 2005
Peripheral neuropathy: a persisting challenge in paclitaxel-based regimesStephan Mielke, Alex Sparreboom, Klaus Mross
Current Opinion in Hematology|October 9, 2014
Diagnosis and treatment of cytomegalovirus 2013Hermann Einsele, Stephan Mielke, Götz Ulrich Grigoleit
In Vivo (Athens, Greece)|November 6, 2003
Fatal outcome in a patient with metastatic prostate cancer and acquired severe hypogammaglobulinemia with complete absence of mature peripheral blood B-cellsJens Lohr, Stephan Mielke, Michael Lübbert, et al.
Anticancer Research|December 13, 2005
Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimenStephan Mielke, Alex Sparreboom, Dirk Behringer, et al.
Frontiers in Immunology|July 8, 2026
Long term survival in three pancreatic cancer patients following Whipple's procedure and allogeneic hematopoietic cell transplantationOlle Ringden, Behnam Sadeghi, Johan Törlen, et al.
Clinical Transplantation|October 8, 2014
Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimusMathias Lutz, Markus Kapp, Hermann Einsele, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 30, 2019
Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazoleVerena Luber, Mathias Lutz, Marianne Abele-Horn, et al.
Bone Marrow Transplantation|February 25, 2022
Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaHannes Lindahl, Sofie Vonlanthen, Davide Valentini, et al.
Pageof 13